Literature DB >> 16844677

TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis.

Ian R Sanderson1, W Allan Walker.   

Abstract

The innate immune system includes microbial pattern recognition receptors that detect bacteria and viral products at the cell surface, in vesicles, and within the cytoplasm. Transmembrane signaling occurs through Toll-like receptors (TLRs). Cytoplasmic receptors are generally members of the nucleotide-binding domain (NOD)-leucine-rich repeat (LRR) family (CATERPILLER family). They influence the effects of other family members and of TLRs. Most NOD-LRR members enhance signal transduction, but Monarch-1 counterbalances TLR activity. NOD-LRR family members also act within the adaptive immune system. The class II transactivator regulates major histocompatibility complex class II expression. In the intestine, it is developmentally regulated, and its expression depends on weaning and, independently, on age.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844677      PMCID: PMC3208512          DOI: 10.1152/ajpgi.00275.2006

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  25 in total

1.  The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.

Authors:  Kristi L Williams; John D Lich; Joseph A Duncan; William Reed; Prasad Rallabhandi; Christopher Moore; Sherry Kurtz; V McNeil Coffield; Mary A Accavitti-Loper; Lishan Su; Stefanie N Vogel; Miriam Braunstein; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

2.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages.

Authors:  Luigi Franchi; Amal Amer; Mathilde Body-Malapel; Thirumala-Devi Kanneganti; Nesrin Ozören; Rajesh Jagirdar; Naohiro Inohara; Peter Vandenabeele; John Bertin; Anthony Coyle; Ethan P Grant; Gabriel Núñez
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

Review 3.  Familial mediterranean fever in Arabs.

Authors:  Hatem El-Shanti; Hasan Abdel Majeed; Mohammed El-Khateeb
Journal:  Lancet       Date:  2006-03-25       Impact factor: 79.321

4.  Cryopyrin activates the inflammasome in response to toxins and ATP.

Authors:  Sanjeev Mariathasan; David S Weiss; Kim Newton; Jacqueline McBride; Karen O'Rourke; Meron Roose-Girma; Wyne P Lee; Yvette Weinrauch; Denise M Monack; Vishva M Dixit
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

5.  Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.

Authors:  Thirumala-Devi Kanneganti; Nesrin Ozören; Mathilde Body-Malapel; Amal Amer; Jong-Hwan Park; Luigi Franchi; Joel Whitfield; Winfried Barchet; Marco Colonna; Peter Vandenabeele; John Bertin; Anthony Coyle; Ethan P Grant; Shizuo Akira; Gabriel Núñez
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

6.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

7.  Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization.

Authors:  J-W Yu; J Wu; Z Zhang; P Datta; I Ibrahimi; S Taniguchi; J Sagara; T Fernandes-Alnemri; E S Alnemri
Journal:  Cell Death Differ       Date:  2006-02       Impact factor: 15.828

Review 8.  CATERPILLERs, pyrin and hereditary immunological disorders.

Authors:  Jenny P-Y Ting; Daniel L Kastner; Hal M Hoffman
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

9.  Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1.

Authors:  Fayyaz S Sutterwala; Yasunori Ogura; Marian Szczepanik; Maria Lara-Tejero; G Scott Lichtenberger; Ethan P Grant; John Bertin; Anthony J Coyle; Jorge E Galán; Philip W Askenase; Richard A Flavell
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

10.  Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection.

Authors:  Parjeet K Boughan; Richard H Argent; Mathilde Body-Malapel; Jong-Hwan Park; Katie E Ewings; Andrew G Bowie; Shao Jin Ong; Simon J Cook; Ole E Sorensen; Barbara A Manzo; Naohiro Inohara; Nigel J Klein; Gabriel Nuñez; John C Atherton; Mona Bajaj-Elliott
Journal:  J Biol Chem       Date:  2006-03-02       Impact factor: 5.157

View more
  14 in total

1.  Infection with Mycobacterium avium subsp. paratuberculosis results in rapid interleukin-1β release and macrophage transepithelial migration.

Authors:  Elise A Lamont; Scott M O'Grady; William C Davis; Torsten Eckstein; Srinand Sreevatsan
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Dietary modulation of GALT.

Authors:  Ian R Sanderson
Journal:  J Nutr       Date:  2007-11       Impact factor: 4.798

3.  The role of the immune system in regulating the microbiota.

Authors:  Benjamin P Willing; Navkiran Gill; B Brett Finlay
Journal:  Gut Microbes       Date:  2010-03-04

4.  Modulation of early β-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunity.

Authors:  Vijay Morampudi; Michel Y Braun; Sushila D'Souza
Journal:  Infect Immun       Date:  2011-03-07       Impact factor: 3.441

5.  Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.

Authors:  Yolanda F M Tolentino; Paula Peruzzi Elia; Homero Soares Fogaça; Antonio José V Carneiro; Cyrla Zaltman; Rodrigo Moura-Neto; Ronir Raggio Luiz; Maria da Gloria C Carvalho; Heitor S de Souza
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

Review 6.  Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.

Authors:  C T Peterson; V Sharma; L Elmén; S N Peterson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

Review 7.  Recent advances in small bowel diseases: Part I.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

8.  ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.

Authors:  Sung Hee Lee; Li-Li Hu; Jose Gonzalez-Navajas; Geom Seog Seo; Carol Shen; Jonathan Brick; Scott Herdman; Nissi Varki; Maripat Corr; Jongdae Lee; Eyal Raz
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

9.  Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Authors:  Jin Wang; Yannan Ouyang; Yigit Guner; Henri R Ford; Anatoly V Grishin
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

10.  Early response of mucosal epithelial cells during Toxoplasma gondii infection.

Authors:  Chia-Hsin Ju; Annapoorani Chockalingam; Cynthia A Leifer
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.